Compare AbbVie Inc (ABBV) vs C.H. Robinson Worldwide, Inc. (CHRW) Price & Performance

AbbVie IncTrade

C.H. Robinson Worldwide, Inc.Trade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs C.H. Robinson Worldwide, Inc. — how do they compare? AbbVie Inc trades at $249.94 (market cap $441.94B), while C.H. Robinson Worldwide, Inc. trades at $145.4 (market cap $16.96B). The key difference: AbbVie Inc is far larger — about 26.1× C.H. Robinson Worldwide, Inc.'s market cap, and AbbVie Inc pays the higher dividend (2.77%). Which is the better fit depends on your goals.

	ABBV	CHRW
Market Cap	$441.94B	$16.96B
Sector	Health	Industrials
52-Week High	$263.58	$209.42
52-Week Low	$197.38	$118.77
Enterprise Value	$506.19B	$18.78B
Dividend Yield	2.77%	1.74%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

C.H. Robinson Worldwide, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 23 hours agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

CHRW

View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About C.H. Robinson Worldwide, Inc.

C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.